EPE0940 Intimate partner violence, depressive symptoms, hazardous alcohol use, and social support among people with HIV initiating HIV care in CameroonE-posterIntegration of HIV services with other health and support services
TUPED10 Introducing the DOME model as a community ‘one-stop’ shop focusing on key populations in Ho Chi Minh City, VietnamPoster exhibitionKey populations and other vulnerable populations: Behavioural, social and cultural issues and contexts
EPB0116 Introduction of near point of care testing platform for early infant HIV diagnosis in NigeriaE-posterDiagnostic and monitoring tools
EPC0302 Investigating the associations between drought, poverty, high-risk sexual behaviours, and HIV incidence in Sub-Saharan Africa: a cross-sectional studyE-posterEpidemiology of HIV
EPE0801 Involving female sex workers in demand creation for Voluntary Medical Male Circumcision (VMMC) services in Chikwawa district, MalawiE-posterImplementation science and scale up of prevention
EPC0419 iPARTY: increasing Pre-Exposure Prophylaxis (PrEP) access and reach through telehealth for young men who have sex with men (YMSM) in SingaporeE-posterPopulation-specific interventions for HIV prevention
OAB0103 Is the recommended valganciclovir dosing for treatment of cytomegalovirus in infants adequate for treatment of cytomegalovirus pneumonia in HIV-positive infants in sub-Saharan Africa? A pharmacokinetic sub-study in the EMPIRICAL trialOral abstract session with live Q&AAntiretroviral therapies and clinical issues in infants, children and adolescents
EPB0219 Islatravir (MK-8591) has no meaningful effect on the pharmacokinetics of atorvastatin and metformin following coadministrationE-posterAntiretroviral therapies and clinical issues in adults
TUPEC07 Just how far off target are we? Measuring unmet pre-exposure prophylaxis (PrEP) need among men who have sex with men (MSM) and transgender women (TGW) in AsiaPoster exhibitionPopulation-specific interventions for HIV prevention
OALBE0605 Key population-led same-day antiretroviral therapy initiation hubs in Bangkok, Thailand: an evaluation of HIV cascade outcomes from a hybrid type 3 implementation-effectiveness trialOral abstract session with live Q&AImplementation science and scale up of treatment
821 - 830 of 1427 items